Article
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients.
European journal of haematology - 1 Jul 2018
Tien Feng-Ming, Hou Hsin-An, Tsai Cheng-Hong, Tang Jih-Luh, Chen Chien-Yuan, Kuo Yuan-Yeh, Li Chi-Cheng, Lin Chien-Ting, Yao Ming, Huang Shang-Yi, Ko Bor-Sheng, Hsu Szu-Chun, Wu Shang-Ju, Tsay Woei, Tseng Mei-Hsuan, Liu Ming-Chih, Liu Chia-Wen, Lin Liang-In, Chou Wen-Chien, Tien Hwei-Fang
Abstract excerpt
OBJECTIVES: Acute myeloid leukemia (AML) with hyperleukocytosis (HL) is intuitively thought as a unique group with dismal prognosis. However, comprehensive studies regarding the genetic landscape and clinical outcome in this group of patients are limited. METHODS: A total of 693 newly diagnosed de novo non-M3 AML patients were consecutively enrolled. We compared relevant mutations in 20 genes between AML patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
